Dow Down 0.22% Nasdaq Up 0.14%

Immunomedics Inc. (IMMU)

-NasdaqGM
3.44 Up 0.11(3.30%) Aug 22, 3:59PM EDT
Prev Close:3.33
Open:3.31
Bid:3.27 x 3000
Ask:3.45 x 4900
1y Target Est:8.33
Beta:0.71
Next Earnings Date:N/A
Day's Range:3.29 - 3.45
52wk Range:3.04 - 7.35
Volume:443,357
Avg Vol (3m):522,467
Market Cap:287.26M
P/E (ttm):N/A
EPS (ttm):-0.38
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMMU

Comparison

Symbol% ChgMkt Cap
IMMUUp 3.30%287.26M
BIIBUp 0.39%80.28B
GSKDown 0.04%114.53B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):30.17
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-14) :-0.39
Quarterly EPS Est (Jun-14) :-0.12
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Immunomedics, Inc., a biopharmaceutical company, focuses on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune, and other serious diseases. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback